Published in Schizophr Res on June 01, 1993
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia | NCT00169039
Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med (1987) 7.13
Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry (1999) 5.29
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry (1993) 4.98
Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex (2001) 4.03
Sexual orientation and suicidality: a co-twin control study in adult men. Arch Gen Psychiatry (1999) 3.97
Biogenic amines and emotion. Science (1967) 3.49
Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics (1991) 3.24
Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry (1980) 2.60
Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry (2001) 2.33
The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol (2001) 2.25
Side effects and the "blindability" of clinical drug trials. Am J Psychiatry (1992) 2.13
NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet (1998) 2.09
Are there sex differences in neuropsychological functions among patients with schizophrenia? Am J Psychiatry (1998) 2.08
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry (1999) 2.04
Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet (2009) 1.92
The heritability of alcoholism symptoms: "indicators of genetic and environmental influence in alcohol-dependent individuals" revisited. Alcohol Clin Exp Res (1999) 1.88
Differential heritability of adult and juvenile antisocial traits. Arch Gen Psychiatry (1995) 1.88
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry (1990) 1.82
Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry (2008) 1.78
Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun (2001) 1.74
Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet (1999) 1.72
Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (1998) 1.72
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. Psychopharmacol Bull (1988) 1.66
Panic and phobic anxiety: defining phenotypes for genetic studies. Am J Psychiatry (1998) 1.66
Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. J Consult Clin Psychol (1994) 1.65
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet (2007) 1.55
Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry (1990) 1.55
Genetic and environmental contributions to smoking. Addiction (1997) 1.55
Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull (1994) 1.55
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Measuring diagnostic accuracy in the absence of a "gold standard". Am J Psychiatry (1994) 1.52
Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol (1989) 1.51
Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity. J Child Psychol Psychiatry (1993) 1.48
Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry. Am J Psychiatry (1992) 1.47
Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet (2001) 1.47
Results, charges, and benefits of intensive care for critically ill patients: update 1983. Crit Care Med (1984) 1.46
A registry-based twin study of depression in men. Arch Gen Psychiatry (1998) 1.45
Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol (1995) 1.44
Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry (1981) 1.43
A homeless person with bipolar disorder and a history of serious self-mutilation. Am J Psychiatry (2000) 1.41
Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol Psychiatry (1999) 1.39
Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry (1986) 1.38
Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med (1996) 1.38
Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord (2000) 1.36
Environmental correlates of infant blood lead levels in Boston. Environ Res (1985) 1.35
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry (2000) 1.35
Correlates of low-level lead exposure in urban children at 2 years of age. Pediatrics (1986) 1.35
Early sensory-motor development and prenatal exposure to lead. Neurobehav Toxicol Teratol (1985) 1.34
Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry (1991) 1.32
An epidemiological assessment of immunization programme participation in the Philippines. Int J Epidemiol (1985) 1.32
The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol (2000) 1.32
Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol (1993) 1.28
Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol Psychiatry (1994) 1.28
Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (1998) 1.26
Do genes influence exposure to trauma? A twin study of combat. Am J Med Genet (1993) 1.24
Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype. Psychol Med (1997) 1.22
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry (2003) 1.22
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol (1995) 1.21
Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry (1997) 1.19
Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol (1986) 1.19
Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction (1998) 1.19
Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry (1995) 1.18
Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet (2001) 1.18
Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival. Arch Gen Psychiatry (1980) 1.18
Suicide in schizophrenics, manics, depressives, and surgical controls. A comparison with general population suicide mortality. Arch Gen Psychiatry (1978) 1.18
Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biol Psychiatry (2000) 1.18
Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry (1978) 1.17
How do genes influence marijuana use? The role of subjective effects. Addiction (1997) 1.15
Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. J Abnorm Psychol (1999) 1.15
Schizophrenia among first-degree relatives of paranoid and nonparanoid schizophrenics. Compr Psychiatry (1974) 1.15
Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry (1991) 1.14
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change. J Consult Clin Psychol (1999) 1.14
Lithium kinetics in single daily dosing. Acta Psychiatr Scand (1981) 1.14
Criteria for subtyping schizophrenia. Clinical differentiation of hebephrenic and paranoid schizophrenia. Arch Gen Psychiatry (1974) 1.13
Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Arch Gen Psychiatry (1981) 1.12
Drosophila polyribosomes. The characterization of two populations by cell fractionation and isotopic labeling with nucleic acid and protein precursors. J Cell Biol (1970) 1.12
A twin study of genetic and environmental influences on suicidality in men. Psychol Med (2002) 1.12
Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatry (2000) 1.11
Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic. J Affect Disord (2000) 1.11
Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet (2008) 1.11
Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch Gen Psychiatry (1985) 1.10
A family history study of schizo-affective disorder. Biol Psychiatry (1977) 1.10
Neuropsychological consequences of regular marijuana use: a twin study. Psychol Med (2004) 1.10
A functional magnetic resonance imaging study of auditory vigilance with low and high information processing demands. Neuropsychology (1998) 1.09
Family history models of alcoholism: age of onset, consequences and dependence. J Stud Alcohol (1993) 1.09
Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry (2008) 1.09
Lead, IQ and social class. Int J Epidemiol (1989) 1.08
The Iowa 500: affective disorder in relatives of manic and depressed patients. Am J Psychiatry (1982) 1.08
Association of neuropsychological vulnerability markers in relatives of schizophrenic patients. Schizophr Res (1998) 1.08
IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am J Psychiatry (1998) 1.08
Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology (1999) 1.08
Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet (2001) 1.07